Year |
Citation |
Score |
2009 |
Saxena C, Bonacci TM, Huss KL, Bloem LJ, Higgs RE, Hale JE. Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool. Journal of Proteome Research. 8: 3951-7. PMID 19537828 DOI: 10.1021/pr900277x |
0.416 |
|
2008 |
Zhao Y, Chen YQ, Bonacci TM, Bredt DS, Li S, Bensch WR, Moller DE, Kowala M, Konrad RJ, Cao G. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. The Journal of Biological Chemistry. 283: 8258-65. PMID 18195019 DOI: 10.1074/Jbc.M710422200 |
0.316 |
|
2006 |
Bonacci TM, Mathews JL, Yuan C, Lehmann DM, Malik S, Wu D, Font JL, Bidlack JM, Smrcka AV. Differential targeting of Gbetagamma-subunit signaling with small molecules. Science (New York, N.Y.). 312: 443-6. PMID 16627746 DOI: 10.1126/Science.1120378 |
0.467 |
|
2006 |
Mahon MJ, Bonacci TM, Divieti P, Smrcka AV. A docking site for G protein βγ subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways. Molecular Endocrinology (Baltimore, Md.). 20: 136-46. PMID 16099817 DOI: 10.1210/Me.2005-0169 |
0.707 |
|
2005 |
Davis TL, Bonacci TM, Sprang SR, Smrcka AV. Structural and molecular characterization of a preferred protein interaction surface on G protein beta gamma subunits. Biochemistry. 44: 10593-604. PMID 16060668 DOI: 10.1021/Bi050655I |
0.686 |
|
2005 |
Malik S, Ghosh M, Bonacci TM, Tall GG, Smrcka AV. Ric-8 enhances G protein betagamma-dependent signaling in response to betagamma-binding peptides in intact cells. Molecular Pharmacology. 68: 129-36. PMID 15802611 DOI: 10.1124/Mol.104.010116 |
0.694 |
|
2005 |
Bonacci TM, Ghosh M, Malik S, Smrcka AV. Regulatory interactions between the amino terminus of G-protein betagamma subunits and the catalytic domain of phospholipase Cbeta2. The Journal of Biological Chemistry. 280: 10174-81. PMID 15611108 DOI: 10.1074/Jbc.M412514200 |
0.62 |
|
Low-probability matches (unlikely to be authored by this person) |
2012 |
Bonacci TM, Hirsch DS, Shen Y, Dokmanovic M, Wu WJ. Small GTPase Rho regulates R-cadherin through Dia1/profilin-1. Cellular Signalling. 24: 2102-10. PMID 22820501 DOI: 10.1016/j.cellsig.2012.07.015 |
0.1 |
|
2011 |
Dokmanovic M, Shen Y, Bonacci TM, Hirsch DS, Wu WJ. Trastuzumab regulates IGFBP-2 and IGFBP-3 to mediate growth inhibition: implications for the development of predictive biomarkers for trastuzumab resistance. Molecular Cancer Therapeutics. 10: 917-28. PMID 21487052 DOI: 10.1158/1535-7163.MCT-10-0980 |
0.067 |
|
Hide low-probability matches. |